TY - JOUR AU - DIVYA, AU - SINGH, INDERBIR AU - NAGAICH, UPENDRA PY - 2021/07/07 Y2 - 2024/03/29 TI - FLUCONAZOLE NANOGEL: FABRICATION AND IN VITRO EVALUATION FOR TOPICAL APPLICATION JF - International Journal of Applied Pharmaceutics JA - Int J App Pharm VL - 13 IS - 4 SE - Original Article(s) DO - 10.22159/ijap.2021v13i4.40531 UR - https://journals.innovareacademics.in/index.php/ijap/article/view/40531 SP - 272-277 AB - <p><strong>Objective</strong>: The aim of this study is to develop and <em>in vitro</em> evaluation of prepared fluconazole nanogel for seborrheic dermatitis</p><p><strong>Methods</strong>: Fluconazole nanogel was formulated to act against seborrheic dermatitis. The fluconazole nanoparticles were prepared by a simplified evaporation method and evaluated for particle size, entrapment efficiency, and percent <em>in vitro</em> drug release. The nanogel was also characterized based on parameters like particle size, percent entrapment efficiency, shape surface morphology, rheological properties, <em>in vitro</em> release <em>R² = 0.9046</em>, and release kinetics.</p><p><strong>Results</strong>: The nanoparticle with a combination of Eudragit RS and Tween 80 showed the best result with particle size in the range of 119.0 nm to 149.5 nm, with a cumulative percent drug release of 95 % up to 18 h. The formulated nanogel with optimum concentration of HPMC authenticate with particle size 149.50±0.5 with maximum drug release (92.13±0.32) %.</p><p><strong>Conclusion</strong>: Different percentages of polymers (ethyl-cellulose, eudragit, and tween 80) are used as variable components in the formulation of nanogel. The optimized batch showed good physical properties (flow index, spreadability, and viscosity) along with rapid drug release. Therefore, it can be concluded that nanogel containing fluconazole has potential application in topical delivery.</p> ER -